Table 5.

The correlation between PPARγ expression and clinicopathologic features of patients with UC after RT

	n	PPARγ protein expression		p	PPARγ mRNA expression	p
		-	+
UC/RT	54	35	19		3.83 ± 0.31
Urothelium	54	7	47	0.001	6.73 ± 0.65	0.000
Gender
Male	5	3	2		3.76 ± 0.27
Female	49	32	17	0.232	3.84 ± 0.29	0.783
Age (years)
<60	43	28	15		3.82 ± 0.31
≥60	11	7	4	0.512	3.84 ± 0.28	0.672
Tumor size
<3 cm	32	19	13		4.74 ± 0.37
≥3 cm	22	16	6	0.002	2.48 ± 0.24	0.000
Histologic grade
I	24	13	11		4.88 ± 0.42
II	18	12	6		3.57 ± 0.31
III	12	10	2	0.001	2.07 ± 0.19	0.000
Clinical stage
Ta-T1	36	21	15		4.15 ± 0.38
T2-T4	18	14	4	0.002	3.18 ± 0.34	0.005
Recurrence
-	31	17	14		5.12 ± 0.49
+	23	18	5	0.001	2.08 ± 0.22	0.000